Liquidia (LQDA) CFO Kaseta sells 142,390 shares after exercising options
Rhea-AI Filing Summary
Liquidia Corp CFO and COO Michael Kaseta reported option exercises and share sales in April 2026. He exercised incentive stock options to acquire a total of 89,971 shares of common stock at an exercise price of $2.79 per share, from options that were fully vested as of November 30, 2024.
Kaseta then sold an aggregate 142,390 shares of common stock in open-market transactions on April 14–15, 2026 at prices including $40.00 and a volume‑weighted average price of $40.1409, within a range of $40.00 to $40.39. These sales were made under a Rule 10b5‑1 trading plan adopted on November 5, 2025. Following the transactions, he directly holds 353,356 shares of common stock, plus additional unvested RSUs and ESPP shares noted in the footnotes.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Incentive Stock Option (right to buy) | 86,971 | $0.00 | $0.00 |
| Sale | Common Stock | 9,044 | $40.1409 | $363K |
| Exercise | Common Stock | 86,971 | $2.79 | $243K |
| Sale | Common Stock | 86,971 | $40.1409 | $3.49M |
| Sale | Common Stock | 43,375 | $40.1409 | $1.74M |
| Exercise | Incentive Stock Option (right to buy) | 3,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,000 | $2.79 | $8K |
| Sale | Common Stock | 3,000 | $40.00 | $120K |
Footnotes (7)
- F1. Includes (i) 23,375 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 40,797 unvested RSUs and 21,875 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 77,547 unvested RSUs of the 112,797 RSUs granted to the Reporting Person on January 11, 2025, (iv) 59,320 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan ("ESPP").
- F2. Represents the subsequent sale of the underlying shares from the exercise of stock options on April 14, 2026 reported on this Form 4. Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025.
- F3. Represents the subsequent sale of shares acquired under the ESPP reported on this Form 4. Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025.
- F4. Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $40.00 to $40.39. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. Represents the subsequent sale of the underlying shares from the exercise of stock options on April 15, 2026 reported on this Form 4. Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025.
- F6. Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025.
- F7. The option vested over a four-year period with 25% vesting on November 30, 2021 and the remaining 75% vesting ratably on a monthly basis over three years thereafter and became fully vested on November 30, 2024.
Key Figures
Key Terms
Incentive Stock Option financial
Rule 10b5-1 plan regulatory
restricted stock units ("RSUs") financial
Employee Stock Purchase Plan ("ESPP") financial
volume weighted average price financial
AI-generated analysis. How Rhea-AI works. Not financial advice.